Kimelman & Baird’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257 Hold
4
﹤0.01% 255
2026
Q1
$285 Hold
4
﹤0.01% 256
2025
Q4
$329 Sell
4
-1,000
-100% -$77.9K ﹤0.01% 257
2025
Q3
$75.4K Sell
1,004
-8
-0.8% -$597 0.01% 159
2025
Q2
$75K Hold
1,012
0.01% 163
2025
Q1
$81.7K Hold
1,012
0.01% 157
2024
Q4
$79.1K Sell
1,012
-808
-44% -$68.7K 0.01% 162
2024
Q3
$171K Sell
1,820
-1,666
-48% -$140K 0.01% 131
2024
Q2
$272K Buy
+3,486
New +$284K 0.02% 117

Other funds holding GEHC

Kimelman & Baird's GEHC Position: Q2 2026 in Review

Kimelman & Baird held its GE HealthCare (GEHC) position steady in Q2 2026 at 4 shares worth $257. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Kimelman & Baird first reported a position in GEHC in Q2 2024 and has held it in 9 quarters since. The position peaked at $272K in Q2 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Kimelman & Baird held 4 shares of GE HealthCare worth $257 as of Q2 2026.
  • Kimelman & Baird left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Kimelman & Baird's portfolio in Q2 2026, its #255 holding.
  • Kimelman & Baird first reported a position in GE HealthCare in Q2 2024 and has held it in 9 quarters since.
  • Kimelman & Baird's GE HealthCare position peaked at $272K in Q2 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.